Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts

Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts

Tilray’s FL Group Teams Up with Molteni, a Major Pharmaceutical Firm Focused on Pain and Substance Dependence Therapies...

Tilray Medical Partners With Molteni to Expand Access to Medical Marijuana in Italy

The Marijuana Herald - Marijuana news and information Tilray Medical, a division of Tilray Brands, has entered into a strategic partnership with Italian pharmaceutical company Molteni Farmaceutici to expand access to medical marijuana extracts for patients across Italy. Under the agreement, Tilray’s wholly-owned subsidiary, FL Group, will work with Molteni to increase availability of EU-GMP certified cannabis therapies while also boosting educat…

Tilrays Strategic Pivot in Italy Amidst Revenue Challenges

In a strategic move aimed at expanding its footprint in the European medical cannabis market, Tilray Medical has announced a new partnership in Italy with the renowned pharmaceutical firm Molteni. This collaboration is poised to enhance access to Tilray's medical cannabis extracts in a region with growing demand for alternative pain and substance dependence therapies. Molteni, a leading company specialized in pain management and treatments for s…

Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Cannabis Extracts

Tilray's FL Group teamed up with Molteni, a major pharmaceutical firm focused on pain and substance dependence therapies.